Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedResults for the RELIVE study have been posted on the page, and the Study Record Dates now show a Results First Posted date of 2021-06-02.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 release; removal of the old v3.1.0 tag.SummaryDifference2%

- Check32 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check46 days agoChange DetectedUpdated the location from Bourgoin-Jallieu, France, 38302 to Bourgoin, France, 38302 and bumped the revision from v3.0.1 to v3.0.2; removed the 'Back to Top' link. This is a minor editorial change with no impact on pricing, stock, or time-slot availability.SummaryDifference0.2%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, while removing several previous location entries and specific drug names. The revision number has also been updated to v3.0.0.SummaryDifference5%

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.